Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
2 other identifiers
observational
396
1 country
1
Brief Summary
Background: Malaria is a disease that affects many people in Liberia. It is caused by germs (parasites) that are spread by mosquito bites. Researchers want to gather data that may help them understand the best way to use a malaria vaccine in Liberia, which will be important in getting rid of the disease. Objective: To find out how often people of all ages who live in Fleh-la and Marshansue, Liberia, get malaria. Eligibility: Healthy people ages 6 months and older who live in Fleh-la and Marshansue in a household with adults and children. Design: Participants will be screened with a physical exam and questions about their health. Participants will have monthly study visits. They will be asked about any symptoms of malaria and their use of bednets. Their vital signs, such as blood pressure and temperature, will be checked. Blood will be taken from the participant s arm or finger with a needle. If they have a fever, they will get a malaria test. If positive, they will get drugs to treat malaria. Once a month, participants houses will be examined for mosquitoes. The team will remove all mosquitoes they collect. As part of this collection, participants houses will be sprayed with a chemical to kill mosquitoes and other insects. Participants will not be allowed in their house while the team is inside. The spray will not harm the participants. Once a year, at the monthly visit, an additional blood sample will be taken. Some of the participants blood samples will be used for genetic testing. Participation will last for up to 3 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2021
CompletedFirst Posted
Study publicly available on registry
January 12, 2021
CompletedStudy Start
First participant enrolled
September 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedJanuary 16, 2026
January 6, 2026
1.6 years
January 9, 2021
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of Monthly rates of blood smear positive individuals by age
Rate of blood smear positive individuals
one year
Study Arms (4)
0.5 - 5 years
Age bracket for infants/children up to age five years
10 - 18 years
Age bracket for children 10 - 18 years
19 + years
Age bracket for adults over 19 years
5 - 10 years
Age bracket for children ages 5 - 10 years
Eligibility Criteria
An estimated total of 400 volunteers from Fleh-la and Marshansue and surrounding villages will be enrolled. Participants above the age of six months will be approached to participate in the study; and will be followed for up to 3 years.
You may qualify if:
- months of age and above
- Known resident of Fleh-la and Marshansue or the surrounding villages and planning to remain for duration of study
- Willingness to allow stored laboratory specimens to be used for future research
- Acceptance and signature of the written informed consent and the assent for children aged 12-17 years who are not otherwise emancipated
- To be eligible for participation, households must meet the following criteria:
- Household with at least 3 residents eligible for participation.
- Household with at least one compound member who is below 18 years of age whose parents or caretakers are willing to provide informed consent for the child to participate.
- Household members willing to accommodate mosquito sampling in their compound, both indoors and outdoors.
You may not qualify if:
- Behavioral, cognitive, or psychiatric disease that in the opinion of the investigator affects the ability of the subject to understand and cooperate with the study protocol.
- Other condition that, in the opinion of the investigator, would jeopardize the safety or rights of a volunteer participating in the trial or would render the subject unable to comply with the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Public Health Institute of Liberia (NPHIL)
Fleh-la, Liberia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer C Hume
National Institute of Allergy and Infectious Diseases (NIAID)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2021
First Posted
January 12, 2021
Study Start
September 30, 2021
Primary Completion
April 28, 2023
Study Completion
February 28, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01-06
Data Sharing
- IPD Sharing
- Will not share